Shares of Health Care sector company Series moved -2.4% today, and are now trading at a price of $351.6. The Large-Cap stock's daily volume was 1,293,735 compared to its average volume of 1,507,715. The S&P 500 index returned a 0.0% performance.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company is based in Conshohocken and has 47,000 full time employees. Its market capitalization is $68,208,095,232. Series currently offers its equity investors a dividend that yields 0.6% per year.
14 analysts are following Series and have set target prices ranging from $300.0 to $417.0 per share. On average, they have given the company a rating of buy. At today's prices, COR is trading -8.62% away from its average analyst target price of $384.79 per share.
Over the last year, COR's share price has increased by 44.0%, which represents a difference of 31.4% when compared to the S&P 500. The stock's 52 week high is $377.54 per share whereas its 52 week low is $223.92. With average free cash flows of $2.46 Billion that have been growing at an average rate of 9.1% over the last 5 years, Series is in a position to continue its strong stock performance trend.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 3,484,685 | 487,173 | 2,997,512 | -13.19 |
| 2023 | 3,911,334 | 458,359 | 3,452,975 | 56.47 |
| 2022 | 2,703,088 | 496,318 | 2,206,770 | -0.97 |
| 2021 | 2,666,586 | 438,217 | 2,228,369 | 21.28 |
| 2020 | 2,207,040 | 369,677 | 1,837,363 | -9.66 |
| 2019 | 2,344,023 | 310,222 | 2,033,801 |
